Analysis of Chimerism Following Allogeneic Bone Marrow Transplantation by Fluorescent-in-Situ Hybridization

References

• Champlin R., Goldman J., Gale R. P. Bone marrow transplantation in chronic myelogenous leukemia. Semin Hematol 1988; 25: 74–80
   PubMed Web of Science ®Google Scholar
• Thomas E., Clift R. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989; 73: 861–864
   PubMed Web of Science ®Google Scholar
• Advisory Committee of the International Bone Marrow Transplant Registry. Report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1989; 4: 221–228
   PubMed Web of Science ®Google Scholar
• Ferrara J., Deeg H. J. Graft‐versus‐host disease. N Engl J Med 1992; 324: 667–6A
   Web of Science ®Google Scholar
• Goldman J., Gale R., Bortin M., Biggs J., Champlin R., Gluckman E., Hoffmann R., Horowitz M., Marmont A., McGlave P., Messner H., Rimm A., Rozman C., Speck B., Tura S., Weiner R. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase, increased risk of relapse associated with T‐cell depletion. Ann Intern Med 1988; 108: 806–814
   PubMed Web of Science ®Google Scholar
• Schattenberg A., de Witte T., Salden M., et al. Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte depleted bone marrow is not associated with higher rates of relapse. Blood 1989; 73: 1367–1372
   PubMed Web of Science ®Google Scholar
• Roy D., Cantra Vahi R., Murray C., et al. Natural history of mixed chimerism after bone marrow transplantation with CD6 depleted allogeneic marrow. A stable equilibrium. Blood 1990; 75: 296–304
   PubMed Web of Science ®Google Scholar
• Offit K., Burns J., Cunningham I., et al. Cytogenetic analysis and leukemia relapse in chronic myelogenous leukemia after T‐cell depleted bone marrow transplantation. Blood 1990; 75: 1346–1355
   PubMed Web of Science ®Google Scholar
• Bertheas M., Lafage M., Levy P., et al. Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia. Blood 1981; 78: 3103–3106
   Google Scholar
• Petz L., Yam P., Wallace R., et al. Mixed hematopoietic chimerism following allogeneic bone marrow transplantation for hematologic malignancies. Blood 1987; 70: 1331–1337
   PubMed Web of Science ®Google Scholar
• Bertheas M., Maraninchi D., Lafage M., et al. Partial chimerism after T‐cell depleted allogeneic bone marrow transplantation in leukemic HLA‐matched patients, A cytogenetic documentation. Blood 1988; 72: 89–93
   PubMed Web of Science ®Google Scholar
• Mackinnon S., Barnett L., Heller G., O'Reilly R. Minimal residual disease is more common in patients who have mixed T‐cell chimerism following bone marrow transplantation for chronic myelogenous leukemia. Blood 1993; 82(suppl 1)169, abstract#660
   PubMedGoogle Scholar
• Champlin R., Ho W., Gajewski J., Feig S., Burnison M., Holley G., Greenberg P., Lee K., Schmid I., Giorgi J., Yam P., Petz L., Winston D., Warner N., Reichert T. Selective depletion of CD8+ T‐lymphocytes for pre‐vention of graft‐versus‐host disease after allogeneic bone marrow transplantation. Blood 1990; 76: 418–423
   PubMed Web of Science ®Google Scholar
• Champlin R., Giralt S., Przepiorka D., et al. Selective depletion of CD‐8 positive T‐lymphocytes for allogeneic bone marrow transplantation; engraftment, graft‐versus‐host disease and graft‐versus‐leukemia. Proc Bone Marrow Purging 1992, in press
   Google Scholar
• Przepiorka D., Schapiro S., Schwinghammer T. L., et al. Cyclosporine and methylprednisolone after allogeneic marrow transplantation: Association between low cyclosporine concentration and risk of acute‐graft‐versus host disease. Bone Marrow Transplant 1991; 7: 461–465
   PubMed Web of Science ®Google Scholar
• Thomas E. D., Storb R. Technique for human marrow grafting. Blood 1970; 36: 507–512
   PubMed Web of Science ®Google Scholar
• Deeg H. J. Bone Marrow Transplantation 1990. Processing of Bone Marrow for Transplantation, R. Sacher, L. McCarthy, C. Smit Sibinga. American Association of Blood Banks, Arlington, Va 1990; 1–18
   Google Scholar
• Pinkel D., Straume T., Gray J. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sc USA 1986; 83: 2934–2938
   PubMed Web of Science ®Google Scholar
• McCann S., Lawler M. Mixed chimerism: detection and significance following BMT. Bone Marrow Transplant 1993; 11: 91–94
   PubMed Web of Science ®Google Scholar
• Sparkes M., Crist M., Sparke R., Gale R., Feig S., The UCLA Transplantation Group. Gene markers in human marrow transplantation. Vox Sangui 1977; 33: 202–205
   PubMed Web of Science ®Google Scholar
• Minden M., Messner H., Belch A. Origin of leukemia relapse after bone marrow transplantation detected by restricted fragment length polymorphism. J Clin Invest 1985; 75: 91–93
   PubMed Web of Science ®Google Scholar
• Lawler M., Humphries P., McCann S. Evaluation of mixed chimerism by in‐vitro amplification of the nucleotide repeated sequences using the polymerase chain reaction. Blood 1991; 77: 2504–2514
   PubMed Web of Science ®Google Scholar
• Kwok S., Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237–238
   PubMed Web of Science ®Google Scholar
• Przepiorka D., Gonzales‐Chambers R., Winkelstein A., Rosenfeld C., Shadduck R. Chimerism studies using in situ hybridization for the Y chromosome after T‐cell depleted bone marrow transplantation. Bone Marrow Transplant 1990; 5: 253–257
   PubMed Web of Science ®Google Scholar
• Bar Bmam M., Schattenberg A., de Man Ajm, Hoogenhout J., Boezeman J., de Witte T. Influence of the conditioning regimen on erythrocyte chimerism, graft versus host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow. Bone Marrow Transplant 1992; 9: 293–297
   PubMedGoogle Scholar